Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Respironics buys Novametrix for $90mm in stock

Executive Summary

Respironics (cardiorespiratory ventilators) will acquire Novametrix (cardiac and respiratory monitoring devices) in a tax-free stock swap valued at $90mm, or $8.65 per share to Novametrix (based on Respironics' share price of $34.59), including the assumption of about $6mm in debt. An exact exchange ratio will be based on Respironics' average trading price over a specified period, and is subject to a collar.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock

Related Companies